Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1997-11-17
2000-04-25
Travers, Russell
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
A61K 31135
Patent
active
060544899
ABSTRACT:
The invention relates to the treatment of an immunocompromised human, e.g., an AIDS or HIV positive patient, for the enhancement of lymphocyte activity against opportunistic microbial pathogens or the treatment of any human for the enhancement of lymphocyte activity against tumors using a lymphocyte-activity-enhancing amount of dextrofenfluramine or a pharmaceutically-acceptable acid addition salt thereof.
REFERENCES:
patent: 5502080 (1996-03-01), Hitzig
The Merck Manual, 16th Edition, pp. 166-167, 266-267, 2422-2423, 2736 (1992).
Peter Sheehan et al Clinical & Exp Pharm & Phys vol. 23, pp 465-7, 1996.
Clancy et al Int. J. Immunopharmae vol. 13 (8) pp 1203-12, 1991.
Merck Manual 17ed 1985 pp 155, 789.
Clancy, Jr. John
Goral Joanna
Lorens Stanley A.
Mathews Herbert L.
Riveline Brigitte
Loyola University of Chicago
Travers Russell
LandOfFree
Method for the enhancement of lymphocyte activity against tumors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the enhancement of lymphocyte activity against tumors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the enhancement of lymphocyte activity against tumors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-993752